ERAMUNE-01

• Research type

  Research Study

• Full title

  International, multicenter, randomized, non-comparative controlled study of therapeutic intensification plus immunomodulation in HIV patients with long-term viral suppression

• IRAS ID

  39901

• Contact name

  Mike Youle

• Sponsor organisation

  ORVACS

• Eudract number

  2009-014406-34

• ISRCTN Number

  Not submitted

• Research summary

  The objective of the proposed study is to evaluate a new therapeutic approach leading to HIV eradication of infected patients. The hypothesis is that eradication may be possible by combining the most potent and synergistic antiretroviral drugs, coupled with an immunomodulating agent(immune experimental intervention)that would activate the latently infected cells in order to purge the reservoir of HIV-infected patient while the antiviral combination would block the spread of the virus.

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  10/H0720/9

• Date of REC Opinion

  26 Jan 2010

• REC opinion

  Favourable Opinion